Detailed trial data show Bayer drug alleviates menopause symptoms New data from two late-stage studies of an experimental Bayer drug show it reduced the frequency and severity of...
Lilly’s once-weekly insulin matches daily shots in late-stage tests A once-weekly form of insulin being developed by Eli Lilly proved just as effective at controlling blood sugar in...
Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate San Francisco-based Bolt Biotherapeutics on Tuesday said it is ending development of its lead cancer drug, laying off half...
Eisai sets new revenue target for Alzheimer’s drug Leqembi One of the developers behind the Alzheimer’s disease drug Leqembi has set new revenue expectations that some analysts see...
FogPharma, Artbio join forces to design a different radiopharma drug FogPharma and Artbio, two buzzy biotechnology companies, are betting they can combine their respective technologies to design a new...
Bayer details layoffs as company shake-up continues German pharmaceutical company Bayer eliminated 1,500 roles during the first three months of the year as part of a...
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive...
Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune Takeda Pharmaceutical is betting potentially billions of dollars on drugs designed to slow Alzheimer’s disease by harnessing the immune...
Regeneron gene therapy improves hearing in two children Dive Brief: A profoundly deaf baby who received Regeneron’s experimental gene therapy was able to hear normally within six...
Novo taps another Flagship startup in search for next obesity drugs Novo Nordisk is again turning to a Flagship Pioneering startup to find new weight loss drugs, announcing on Thursday...